Fang, H., Guinto, H. and Pinneboina, H. 2023. Effective Reprogramming Strategies for Treating Diabetes-Related Cancer: A Focus on Fasentin, Metformin, and Panitumumab Therapies. Berkeley Pharma Tech Journal of Medicine. 3, 2 (Dec. 2023), 101–118. DOI:https://doi.org/10.52243/bptjm.v3i2.46.